Trial Profile
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs V 503 (Primary)
- Indications Anal cancer; Cervical cancer; Condylomata acuminata; Human papillomavirus infections; Vulvovaginal cancer
- Focus Pharmacodynamics
- 07 Mar 2024 Planned End Date changed from 31 Dec 2023 to 4 Mar 2025.
- 18 Apr 2023 Planned End Date changed from 31 Mar 2023 to 31 Dec 2023.
- 18 Apr 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Dec 2023.